Method of cardiac imaging with the use of hyperpolarized 13 C-pyruvate

Details for Australian Patent Application No. 2005307194 (hide)

Owner GE Healthcare AS

Inventors Ardenkjaer-Larsen, Jan-Henrik; Thaning, Mikkel; Zandt, Rene; Petersson Stefan; Golman, Klaes; Lerche, Mathilde

Agent Davies Collison Cave

Pub. Number AU-B-2005307194

PCT Pub. Number WO2006/054903

Priority 20045058 19.11.04 NO

Filing date 18 November 2005

Wipo publication date 26 May 2006

Acceptance publication date 10 February 2011

International Classifications

A61K 49/06 (2006.01) Preparations for testing - Nuclear magnetic resonance (NMR) contrast preparations

Event Publications

14 June 2007 PCT application entered the National Phase

  PCT publication WO2006/054903 Priority application(s): WO2006/054903

10 February 2011 Application Accepted

  Published as AU-B-2005307194

9 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005307195-Contrast agents to target extracellular matrix

2005307189-Test method and system for dynamic positioning systems